+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Nicotine Gum Market 2019-2023 - Product Image

Global Nicotine Gum Market 2019-2023

  • ID: 4749718
  • Report
  • January 2019
  • Region: Global
  • 110 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • British American Tobacco
  • GlaxoSmithKline
  • ITC Limited
  • Novartis
  • MORE
Increase in number of people quitting smoking to drive market growth. It is estimated that tobacco will cause more than 8 million deaths annually by 2030. In the US, cigarette smoking is responsible for nearly 480,000 deaths every year. The number of quit attempts it takes before smokers are successful at quitting smoking varies. According to the American Cancer Society, it takes about 8-10 quit attempts, while the Australian Cancer Council suggests that it takes 12-14 attempts to quit the habit of smoking. The analysts have predicted that the nicotine gum market will register a CAGR of over 5% by 2023.

Market Overview

Growing enrolment in smoking cessation therapies

The smoking cessation therapy is gaining popularity among consumers who are trying to quit smoking, and in certain countries, governments are sponsoring smoking cessation therapy programs. In the US, Department of Health and Human Services is sponsoring tobacco cessation programs through its supported health centers. Thus, the increasing application of nicotine gums as a medium to help consumers quit smoking will help in the growth of the global nicotine gums market during the forecast period.

Presence of substitute products

The availability of many substitute products can negatively influence the growth of the market during the forecast period. Nicotine patches, nicotine snus, nasal sprays, inhalers, and lozenges are some of the substitutes to nicotine gum. The emergence of e-cigarettes has considerably challenged the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the nicotine gum market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including GlaxoSmithKline and ITC Limited, the competitive environment is quite intense. Factors such as the growing enrolment in smoking cessation therapies and the increase in number of people quitting smoking, will provide considerable growth opportunities to nicotine gum manufacturers. British American Tobacco, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, and Novartis are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • British American Tobacco
  • GlaxoSmithKline
  • ITC Limited
  • Novartis
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • 2-mg nicotine - Market size and forecast 2018-2023
  • 4-mg nicotine - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • South America - Market size and forecast 2018-2023
  • MEA - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • New product launches
  • Increase in number of people quitting smoking
  • Addiction to nicotine gums
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • British American Tobacco
  • GlaxoSmithKline
  • ITC Limited
  • Johnson & Johnson Services
  • Novartis
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global tobacco market
Exhibit 03: Segments of global tobacco market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: -mg nicotine - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: -mg nicotine - Year-over-year growth 2019-2023 (%)
Exhibit 22: -mg nicotine - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: -mg nicotine - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 34: South America - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: South America - Year-over-year growth 2019-2023 (%)
Exhibit 36: MEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: MEA - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: British American Tobacco - Vendor overview
Exhibit 48: British American Tobacco - Business segments
Exhibit 49: British American Tobacco - Organizational developments
Exhibit 50: British American Tobacco - Geographic focus
Exhibit 51: British American Tobacco - Key offerings
Exhibit 52: GlaxoSmithKline - Vendor overview
Exhibit 53: GlaxoSmithKline - Business segments
Exhibit 54: GlaxoSmithKline - Organizational developments
Exhibit 55: GlaxoSmithKline - Geographic focus
Exhibit 56: GlaxoSmithKline - Segment focus
Exhibit 57: GlaxoSmithKline - Key offerings
Exhibit 58: ITC Limited - Vendor overview
Exhibit 59: ITC Limited - Business segments
Exhibit 60: ITC Limited - Organizational developments
Exhibit 61: ITC Limited - Segment focus
Exhibit 62: ITC Limited - Key offerings
Exhibit 63: Johnson & Johnson Services - Vendor overview
Exhibit 64: Johnson & Johnson Services - Business segments
Exhibit 65: Johnson & Johnson Services - Organizational developments
Exhibit 66: Johnson & Johnson Services - Segment focus
Exhibit 67: Johnson & Johnson Services - Key offerings
Exhibit 68: Novartis - Vendor overview
Exhibit 69: Novartis - Organizational developments
Exhibit 70: Novartis - Segment focus
Exhibit 71: Novartis - Key offerings
Exhibit 72: Validation techniques employed for market sizing
Exhibit 73: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • British American Tobacco
  • GlaxoSmithKline
  • ITC Limited
  • Novartis
  • MORE
Global Nicotine Gum Market 2019-2023

The analyst recognizes the following companies as the key players in the global nicotine gum market: British American Tobacco, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, and Novartis.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in number of people quitting smoking.”

According to the report, one of the major drivers for this market is the growing enrolment in smoking cessation therapies.

Further, the report states that one of the major factors hindering the growth of this market is the presence of substitute products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • British American Tobacco
  • GlaxoSmithKline
  • ITC Limited
  • Johnson & Johnson Services
  • Novartis
Note: Product cover images may vary from those shown
Adroll
adroll